EU Plan Prioritizes Heart Checks for High-Risk Groups

Under the compromise, adults at high cardiovascular risk, including those with type 2 diabetes, would be prioritized for checks.

Updated on Nov. 3, 2026 in Heart Disease

Bold flat-color editorial illustration of a heart with an ECG line, ringed by concentric tiers in deep red and cream.
The EU Council's Irish Presidency has proposed letting member states prioritize cardiovascular checks for adults at high risk, including those with type 2 diabetes. AI Illustration. Upload story photo >

Live Poll

Should your national government set firm targets for heart disease screening?

Irish Presidency of the EU Council presented a compromise on a recommendation on cardiovascular health checks to the Council's Working Party on Public Health on 30 October. The compromise would give Member States flexibility over how cardiovascular checks are carried out, with priority for people at high cardiovascular risk, particularly those with type 2 diabetes.

Why it matters

The compromise responds to national reservations about health targets, available resources and administrative obligations, adapting the European screening ambition to the specifics of national health systems. Cardiovascular disease remains a major burden across the EU, with fewer than half of Member States currently offering cardiovascular health checks.

The figures come from EU policy documents and OECD cost estimates cited in the compromise text. The proposal would still leave the 2035 targets mentioned in the recitals, and Member States would report to the European Commission three years after adoption and every four years thereafter.

The players

Irish Presidency of the EU Council

Holds the rotating EU Council presidency and set out the compromise on the cardiovascular health checks recommendation.

European Commission

The EU executive body that proposed the Safe Hearts Plan and the original cardiovascular health recommendation.

OECD

The Organisation for Economic Co-operation and Development, which estimates the economic cost of cardiovascular diseases at more than €282 billion a year.

The details

The compromise amends the European Commission's 28 September proposal to account for national concerns about targets, resources and administrative duties. Under the text, Member States may adapt both the cardiovascular checks themselves and how often they are performed, as detailed in an annex, to match their populations' needs. Priority is given to people at high cardiovascular risk, particularly those with type 2 diabetes.

Timeline

  1. December 2025: The European Commission presented the Safe Hearts Plan on cardiovascular health.

  2. 28 September: The Commission presented its original recommendation proposal.

  3. 23 October: The compromise text was sent to delegations.

  4. 30 October: The compromise was presented to the Working Party on Public Health in Brussels.

Health Landscape

The EU's cardiovascular burden of 1.7 million deaths a year remains the central problem the recommendation targets. The compromise shows how member states with differing health systems are reshaping an EU-wide screening ambition into flexible national implementation.

Because the recommendation prioritizes people with type 2 diabetes and other high-risk groups, it is worth discussing your cardiovascular risk with your doctor, especially if you have diabetes. Availability of checks will vary by country, so the screening options you can access depend on where you live.

The takeaway

Cardiovascular disease causes about 1.7 million deaths a year in the EU, and checks remain uneven across member states. Ask your doctor whether a cardiovascular risk assessment is appropriate for you, particularly if you have type 2 diabetes.

Further reading

For broader context on the condition, see the Heart Disease section.

More information

Read the original compromise document (French version) on the proposed cardiovascular health checks recommendation.

Source note: This article includes information reported by Agence Europe.

Live Poll

Should your national government set firm targets for heart disease screening?